Drug Search Results
More Filters [+]

Dyclonine

Alternative Names: dyclonine, dyclopro, dyclone
Latest Update: 2017-11-24
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: Voltage-Gated Sodium Channel Blocker

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral,Intravenous,Topical

FDA Designation: None *

Approval Status: Approved

Approved Countries: Canada | India | Peru | Taiwan | United States

Approved Indications: None

Known Adverse Events: None

Company: Beijing Renfujunwei Pharmaceutical Technology Development Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Dyclonine

Countries in Clinic: China

Active Clinical Trial Count: 1

Highest Development Phases

Phase 2: Other

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20221596

P2

Not yet recruiting

Other

None

Recent News Events

Date

Type

Title